financetom
Business
financetom
/
Business
/
Starbucks Stock Rises On Mixed Q4 Earnings: 'It's Clear That Our Turnaround Is Taking Hold'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Starbucks Stock Rises On Mixed Q4 Earnings: 'It's Clear That Our Turnaround Is Taking Hold'
Oct 29, 2025 1:45 PM

Starbucks Corp ( SBUX ) reported financial results for the fourth quarter of fiscal 2025 after the market close on Wednesday. Here’s a look at the key metrics from the print.

SBUX is trending. Check the full analysis here.

Q4 Highlights: Starbucks ( SBUX ) reported fourth-quarter revenue of $9.57 billion, beating analyst estimates of $9.35 billion. The coffee giant reported fourth-quarter adjusted earnings of 52 cents per share, missing analyst estimates of 56 cents per share, according to Benzinga Pro.

Consolidated net revenue was up 5% on a year-over-year basis as global comparable store sales climbed 1%, driven by a 1% increase in comparable transactions.

Comparable store sales were flat in North America and increased 3% internationally. The company said comparable store sales in China were up 2% in the quarter.

“We’re a year into our ‘Back to Starbucks’ strategy, and it’s clear that our turnaround is taking hold,” said Brian Niccol, chairman and CEO of Starbucks ( SBUX ). “Our return to global comp growth and the momentum we’re building give me confidence we’re on the right path to deliver the very best of Starbucks ( SBUX ) for our customers, partners and shareholders.”

Starbucks ( SBUX ) closed 107 stores in the quarter and ended the period with 40,990 total locations. The company said it had approximately $3.22 billion in cash and cash equivalents at quarter's end.

Starbucks’ board declared a cash dividend of 62 cents per share, payable on Nov. 28 to shareholders of record as of Nov. 14.

Starbucks ( SBUX ) executives are currently discussing the quarter on an earnings call that started at 4:15 p.m. ET.

SBUX Price Action: Starbucks ( SBUX ) shares were up 1.81% in after-hours, trading at $85.70 at the time of publication on Wednesday, according to Benzinga Pro.

Read Next:

Starbucks Brews A Turnaround, But Investors Want A Stronger Roast: CEO Says ‘The Stock Will…’ 

Image generated using artificial intelligence via DALL-E.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Former US energy secretary Granholm joins Edison International, Socal Edison boards
Former US energy secretary Granholm joins Edison International, Socal Edison boards
Feb 20, 2025
(Reuters) - Jennifer Granholm, the former U.S. secretary of energy and a Democratic two-term governor of Michigan, has been appointed to the boards of Edison International ( EIX ) and its subsidiary, Southern California Edison, effective April 1, the company announced on Thursday. Granholm brings extensive experience in energy policy, particularly in advancing clean energy initiatives and zero-carbon technologies, from...
Appfolio Insider Sold Shares Worth $760,662, According to a Recent SEC Filing
Appfolio Insider Sold Shares Worth $760,662, According to a Recent SEC Filing
Feb 20, 2025
05:42 PM EST, 02/20/2025 (MT Newswires) -- William Shane Trigg, Director, Chief Executive Officer, on February 18, 2025, sold 3,501 shares in Appfolio ( APPF ) for $760,662. Following the Form 4 filing with the SEC, Trigg has control over a total of 83,824 Class A common shares of the company, with 83,824 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1433195/000143319525000028/xslF345X05/wk-form4_1740090716.xml ...
Gilead Sciences Gets Conditional Marketing Authorization for Liver Disease Treatment in European Economic Area
Gilead Sciences Gets Conditional Marketing Authorization for Liver Disease Treatment in European Economic Area
Feb 20, 2025
05:44 PM EST, 02/20/2025 (MT Newswires) -- Gilead Sciences ( GILD ) said the European Commission granted conditional marketing authorization for seladelpar in combination with ursodeoxycholic acid to treat primary biliary cholangitis, a rare liver disease. The treatment targets adults who have an inadequate response to UDCA alone, or as monotherapy in those unable to tolerate UDCA, the company said...
BRIEF-Celsius Holdings To Acquire Alani Nu
BRIEF-Celsius Holdings To Acquire Alani Nu
Feb 20, 2025
Feb 20 (Reuters) - Celsius Holdings Inc ( CELH ): * CELSIUS HOLDINGS TO ACQUIRE ALANI NU®, CREATING A LEADING BETTER-FOR-YOU, FUNCTIONAL LIFESTYLE PLATFORM * CELSIUS HOLDINGS INC ( CELH ) - TO ACQUIRE ALANI NU FOR $1.65 BILLION * CELSIUS HOLDINGS INC ( CELH ) - DEAL EXPECTED TO BE ACCRETIVE TO CASH EPS IN FIRST YEAR * CELSIUS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved